Here Shmuel Rausnitz writes about his concerns relating to the FDA and foodtech entrepreneur’s tendency to oversimplify consumer demands and needs across demographics.
The US Food and Drug Administration (FDA) has come under fire for not providing more guidelines to food tech companies on what is and what is not allowed.
While it was a positive first step that the FDA addressing the space, how it will play out is still uncertain as participants debated who should regulate the products, what it should be called, and how its safety will be determined.
Monsanto’s lawsuit, cannabis legalization in New Zealand, and continued drama around GMO-labeling are some of the stories covered in this week’s Industry-in-Brief.
This week’s news-in-brief covers the launch of a new crop-spraying drone, a $20m commitment by New Zealand to combat agricultural emissions, and agribusiness PE fund Arlon leads sugar business M&A.
According to the United States Food and Drug Administration (FDA), each year roughly 48 million get sick, 128,000 require hospitalization, and 3,000 lose their lives
Digital Ag: Why is predicting return on investment per field so hard?